KRISPY KREME INC (DNUT) Fundamental Analysis & Valuation

NASDAQ:DNUT • US50101L1061

Current stock price

4.085 USD
+0.1 (+2.64%)
Last:

This DNUT fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. DNUT Profitability Analysis

1.1 Basic Checks

  • In the past year DNUT has reported negative net income.
  • In the past year DNUT had a positive cash flow from operations.
  • In the past 5 years DNUT reported 4 times negative net income.
  • In the past 5 years DNUT always reported a positive cash flow from operatings.
DNUT Yearly Net Income VS EBIT VS OCF VS FCFDNUT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 0 -200M -400M

1.2 Ratios

  • The Return On Assets of DNUT (-20.06%) is worse than 92.86% of its industry peers.
  • DNUT has a Return On Equity of -80.00%. This is in the lower half of the industry: DNUT underperforms 73.02% of its industry peers.
Industry RankSector Rank
ROA -20.06%
ROE -80%
ROIC N/A
ROA(3y)-7.04%
ROA(5y)-4.48%
ROE(3y)-27.65%
ROE(5y)-17.26%
ROIC(3y)N/A
ROIC(5y)N/A
DNUT Yearly ROA, ROE, ROICDNUT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 2025 0 -20 -40 -60

1.3 Margins

  • Looking at the Gross Margin, with a value of 28.98%, DNUT is doing worse than 78.57% of the companies in the same industry.
  • In the last couple of years the Gross Margin of DNUT has remained more or less at the same level.
  • The Profit Margin and Operating Margin are not available for DNUT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 28.98%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.22%
GM growth 5Y-0.06%
DNUT Yearly Profit, Operating, Gross MarginsDNUT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20

0

2. DNUT Health Analysis

2.1 Basic Checks

  • DNUT does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for DNUT has been increased compared to 1 year ago.
  • DNUT has more shares outstanding than it did 5 years ago.
  • DNUT has a worse debt/assets ratio than last year.
DNUT Yearly Shares OutstandingDNUT Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M
DNUT Yearly Total Debt VS Total AssetsDNUT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

2.2 Solvency

  • DNUT has an Altman-Z score of 0.17. This is a bad value and indicates that DNUT is not financially healthy and even has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of 0.17, DNUT is doing worse than 85.71% of the companies in the same industry.
  • A Debt/Equity ratio of 1.40 is on the high side and indicates that DNUT has dependencies on debt financing.
  • DNUT's Debt to Equity ratio of 1.40 is in line compared to the rest of the industry. DNUT outperforms 52.38% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.4
Debt/FCF N/A
Altman-Z 0.17
ROIC/WACCN/A
WACC7.15%
DNUT Yearly LT Debt VS Equity VS FCFDNUT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M 800M 1B

2.3 Liquidity

  • A Current Ratio of 0.38 indicates that DNUT may have some problems paying its short term obligations.
  • Looking at the Current ratio, with a value of 0.38, DNUT is doing worse than 87.30% of the companies in the same industry.
  • A Quick Ratio of 0.32 indicates that DNUT may have some problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 0.32, DNUT is doing worse than 84.92% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.38
Quick Ratio 0.32
DNUT Yearly Current Assets VS Current LiabilitesDNUT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M

3

3. DNUT Growth Analysis

3.1 Past

  • DNUT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -183.33%.
  • Looking at the last year, DNUT shows a decrease in Revenue. The Revenue has decreased by -8.57% in the last year.
  • Measured over the past years, DNUT shows a small growth in Revenue. The Revenue has been growing by 6.30% on average per year.
EPS 1Y (TTM)-183.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%800%
Revenue 1Y (TTM)-8.57%
Revenue growth 3Y-0.16%
Revenue growth 5Y6.3%
Sales Q2Q%-2.88%

3.2 Future

  • The Earnings Per Share is expected to grow by 12.42% on average over the next years. This is quite good.
  • Based on estimates for the next years, DNUT will show a small growth in Revenue. The Revenue will grow by 7.09% on average per year.
EPS Next Y56.4%
EPS Next 2Y27.98%
EPS Next 3Y2.98%
EPS Next 5Y12.42%
Revenue Next Year-1.35%
Revenue Next 2Y1.09%
Revenue Next 3Y3.69%
Revenue Next 5Y7.09%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
DNUT Yearly Revenue VS EstimatesDNUT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B 2B
DNUT Yearly EPS VS EstimatesDNUT Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2030 0 0.2 0.4

0

4. DNUT Valuation Analysis

4.1 Price/Earnings Ratio

  • DNUT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for DNUT. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
DNUT Price Earnings VS Forward Price EarningsDNUT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 -50

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, DNUT is valued a bit more expensive than 65.87% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 17.39
DNUT Per share dataDNUT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 -4 6 8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y27.98%
EPS Next 3Y2.98%

4

5. DNUT Dividend Analysis

5.1 Amount

  • DNUT has a Yearly Dividend Yield of 3.94%.
  • DNUT's Dividend Yield is rather good when compared to the industry average which is at 1.04. DNUT pays more dividend than 93.65% of the companies in the same industry.
  • DNUT's Dividend Yield is rather good when compared to the S&P500 average which is at 1.81.
Industry RankSector Rank
Dividend Yield 3.94%

5.2 History

  • DNUT has been paying a dividend for over 5 years, so it has already some track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
DNUT Yearly Dividends per shareDNUT Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 2025 0.05 0.1 0.15

5.3 Sustainability

  • DNUT has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-2.29%
EPS Next 2Y27.98%
EPS Next 3Y2.98%
DNUT Yearly Income VS Free CF VS DividendDNUT Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2018 2019 2020 2021 2022 2023 2024 2025 0 -200M -400M

DNUT Fundamentals: All Metrics, Ratios and Statistics

KRISPY KREME INC

NASDAQ:DNUT (4/22/2026, 11:43:00 AM)

4.085

+0.1 (+2.64%)

Chartmill FA Rating
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)02-26
Earnings (Next)05-07
Inst Owners43.46%
Inst Owner Change-0.04%
Ins Owners3.22%
Ins Owner Change-0.06%
Market Cap703.44M
Revenue(TTM)1.52B
Net Income(TTM)-520.07M
Analysts53.85
Price Target4.76 (16.52%)
Short Float %23.57%
Short Ratio8.27
Dividend
Industry RankSector Rank
Dividend Yield 3.94%
Yearly Dividend0.07
Dividend Growth(5Y)N/A
DP-2.29%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)151.6%
Min EPS beat(2)118.57%
Max EPS beat(2)184.63%
EPS beat(4)2
Avg EPS beat(4)-12.9%
Min EPS beat(4)-353.46%
Max EPS beat(4)184.63%
EPS beat(8)3
Avg EPS beat(8)-41%
EPS beat(12)5
Avg EPS beat(12)-31.81%
EPS beat(16)7
Avg EPS beat(16)-25.64%
Revenue beat(2)0
Avg Revenue beat(2)-1.63%
Min Revenue beat(2)-2.73%
Max Revenue beat(2)-0.53%
Revenue beat(4)0
Avg Revenue beat(4)-2.28%
Min Revenue beat(4)-4.3%
Max Revenue beat(4)-0.53%
Revenue beat(8)0
Avg Revenue beat(8)-2.13%
Revenue beat(12)2
Avg Revenue beat(12)-1.67%
Revenue beat(16)4
Avg Revenue beat(16)-1.42%
PT rev (1m)7.63%
PT rev (3m)6.1%
EPS NQ rev (1m)0%
EPS NQ rev (3m)8.74%
EPS NY rev (1m)36.03%
EPS NY rev (3m)59.67%
Revenue NQ rev (1m)1.22%
Revenue NQ rev (3m)-5.31%
Revenue NY rev (1m)0.07%
Revenue NY rev (3m)-1.8%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.46
P/FCF N/A
P/OCF 20.74
P/B 1.08
P/tB N/A
EV/EBITDA 17.39
EPS(TTM)-0.1
EYN/A
EPS(NY)-0.04
Fwd EYN/A
FCF(TTM)-0.37
FCFYN/A
OCF(TTM)0.2
OCFY4.82%
SpS8.84
BVpS3.78
TBVpS-4.99
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -20.06%
ROE -80%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 28.98%
FCFM N/A
ROA(3y)-7.04%
ROA(5y)-4.48%
ROE(3y)-27.65%
ROE(5y)-17.26%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.22%
GM growth 5Y-0.06%
F-Score5
Asset Turnover0.59
Health
Industry RankSector Rank
Debt/Equity 1.4
Debt/FCF N/A
Debt/EBITDA 9.78
Cap/Depr 71.44%
Cap/Sales 6.43%
Interest Coverage N/A
Cash Conversion 36.4%
Profit Quality N/A
Current Ratio 0.38
Quick Ratio 0.32
Altman-Z 0.17
F-Score5
WACC7.15%
ROIC/WACCN/A
Cap/Depr(3y)86.1%
Cap/Depr(5y)95.44%
Cap/Sales(3y)6.96%
Cap/Sales(5y)7.36%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-183.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%800%
EPS Next Y56.4%
EPS Next 2Y27.98%
EPS Next 3Y2.98%
EPS Next 5Y12.42%
Revenue 1Y (TTM)-8.57%
Revenue growth 3Y-0.16%
Revenue growth 5Y6.3%
Sales Q2Q%-2.88%
Revenue Next Year-1.35%
Revenue Next 2Y1.09%
Revenue Next 3Y3.69%
Revenue Next 5Y7.09%
EBIT growth 1Y-248.15%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year156.69%
EBIT Next 3Y38.11%
EBIT Next 5Y24.32%
FCF growth 1Y14.61%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-25.98%
OCF growth 3Y-37.63%
OCF growth 5Y3.4%

KRISPY KREME INC / DNUT Fundamental Analysis FAQ

What is the ChartMill fundamental rating of KRISPY KREME INC (DNUT) stock?

ChartMill assigns a fundamental rating of 1 / 10 to DNUT.


What is the valuation status of KRISPY KREME INC (DNUT) stock?

ChartMill assigns a valuation rating of 0 / 10 to KRISPY KREME INC (DNUT). This can be considered as Overvalued.


What is the profitability of DNUT stock?

KRISPY KREME INC (DNUT) has a profitability rating of 1 / 10.


Can you provide the financial health for DNUT stock?

The financial health rating of KRISPY KREME INC (DNUT) is 0 / 10.


Is the dividend of KRISPY KREME INC sustainable?

The dividend rating of KRISPY KREME INC (DNUT) is 4 / 10 and the dividend payout ratio is -2.29%.